The potential of TRPV1 agonists for treating ischemia/reperfusion-induced renal injuries

Current Opinion in Investigational Drugs

Volumn 10, Issue 9, 2009, Pages 963-970

  Rayamajhi, S ^a   Contractor, T ^a   Wang, D H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Agonist; Capsaicin; Inflammation; Ischemia reperfusion; Renal; TRPV1

Indexed keywords

ANTITHROMBIN; ATRIAL NATRIURETIC FACTOR ALPHA; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CAPSAZEPINE; EVODIAMINE; RESINIFERATOXIN; SA 13353; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

HEART PROTECTION; INFLAMMATION; KIDNEY; KIDNEY ISCHEMIA; NERVE CONDUCTION; NONHUMAN; PATHOGENESIS; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW; SENSORY NERVE;

ANIMALS; FORECASTING; INFLAMMATION; KIDNEY DISEASES; NEURONS, AFFERENT; REPERFUSION INJURY; TRPV CATION CHANNELS;

EID: 69549096157     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Rouschop KMA, Leemans JC: Ischemia-reperfusion treatment: Opportunities point to modulation of the inflammatory response. Kidney Int (2008) 73(12):1333-1335.
2. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol (2007) 376(1-2):1-43.
3. Li YJ, Xiao ZS, Peng CF, Deng HW: Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts. Eur J Pharmacol (1996) 311(2-3):163-167. (Pubitemid 26330371)
4. Harada N, Okajima K, Uchiba M, Katsuragi T: Ischemia/reperfusion-induced increase in the hepatic level of prostacyclin is mainly mediated by activation of capsaicin-sensitive sensory neurons in rats. J Lab Clin Med (2002) 139(4):218-226. • Capsaicin and CGRP significantly enhanced I/R-induced increases in hepatic levels of a PGI2 metabolite, leading to increased hepatic blood flow following reperfusion and inhibition of the I/R-induced increase in tissue levels of both TNFα and myeloperoxidase. (Pubitemid 34557356)
5. Nagy I, Sántha P, Jancsó G, Urbán L: The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol (2004) 500(1-3):351-369. (Pubitemid 39304020)
6. Porszasz J, Jancso N: Studies on the action potentials of sensory nerves in animals desensitized with capsaicine. Acta Physiol Acad Sci Hung (1959) 16:299-306.
7. Szallasi A, Blumberg PM: Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor. Life Sci (1990) 47(16):1399-1408.
8. Caterina MJ, Julius D: The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci (2001) 24: 487-517.
9. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA et al: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 405(6783):183-187. (Pubitemid 30313536)
10. de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernández- Ruiz J : Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: In vivo and in vitro evidence. Brain Res (2004) 1007(1-2):152-159. (Pubitemid 38520183)
11. Zheng J, Dai C, Steyger PS, Kim Y, Vass Z, Ren T, Nuttall AL: Vanilloid receptors in hearing: Altered cochlear sensitivity by vanilloids and expression of TRPV1 in the organ of corti. J Neurophysiol (2003) 90(1):444-455. (Pubitemid 36859192)
12. Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, Dineley KE, Watkins S, Reynolds IJ, Caterina MJ: Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA (2001) 98(23):13396-13401. (Pubitemid 33051374)
13. Ueda K, Tsuji F, Hirata T, Ueda K, Murai M, Aono H, Takaoka M, Matsumura Y: Preventive effect of SA13353 [1-[2-(1- adamantyl)ethyl]-1-pentyl-3-[3-(4- pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther (2009) 329(1):202-209. •• The renal-protective effect of pretreatment with SA-13353 in renal I/R-induced injury occurs via the activation of TRPV1, and leads to decreases in TNFα and CINC-1 and increases in IL-10 levels.
14. Keeble J, Russell F, Curtis B, Starr A, Pinter E, Brain SD: Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum (2005) 52(10):3248-3256. (Pubitemid 41447108)
15. Szabó A, Helyes Z, Sándor K, Bite A, Pintér E, Németh J, Bánvölgyi A, Bölcskei K, Elekes K, Szolcsányi J: Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: In vivo study using gene-deficient mice. J Pharmacol Exp Ther (2005) 314(1):111-119.
16. Demirbilek S, Ersoy MO, Demirbilek S, Karaman A, Gürbüz N, Bayraktar N, Bayraktar M: Small-dose capsaicin reduces systemic inflammatory responses in septic rats. Anesth Analg (2004) 99(5):1501-1507. (Pubitemid 39407305)
17. Clark N, Keeble J, Fernandes ES, Starr A, Liang L, Sugden D, de Winter P, Brain SD: The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J (2007) 21(13):3747-3755. (Pubitemid 350075162)
18. Helyes Z, Elekes K, Németh J, Pozsgai G, Sándor K, Kereskai L, Börzsei R, Pintér E, Szabó A, Szolcsányi J: Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse. Am J Physiol Lung Cell Mol Physiol (2007) 292(5):L1173-L1181. (Pubitemid 47084861)
19. Aviado DM, Guevara Aviado D: The Bezold-Jarisch reflex. A historical perspective of cardiopulmonary reflexes. Ann NY Acad Sci (2001) 940:48-58.
20. Franco-Cereceda A, Källner G, Lundberg JM: Capsazepine-sensitive release of calcitonin gene-related peptide from C-fibre afferents in the guinea-pig heart by low pH and lactic acid. Eur J Pharmacol (1993) 238(2-3):311-316. (Pubitemid 23214446)
21. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 400(6743):452-457. (Pubitemid 29361798)
22. Li J, Kaminski NE, Wang DH: Anandamide-induced depressor effect in spontaneously hypertensive rats: Role of the vanilloid receptor. Hypertension (2003) 41(3 Pt 2):757-762. (Pubitemid 36314587)
23. Wang Y, Kaminski NE, Wang DH: VR1-mediated depressor effects during high-salt intake: Role of anandamide. Hypertension (2005) 46(4):986-991.
24. Feng NH, Lee HH, Shiang JC, Ma MC: Transient receptor potential vanilloid type 1 channels act as mechanoreceptors and cause substance P release and sensory activation in rat kidneys. Am J Physiol Renal Physiol (2008) 294(2):F316-F325.
25. Li J, Wang DH: Increased GFR and renal excretory function by activation of TRPV1 in the isolated perfused kidney. Pharmacol Res (2008) 57(3):239-246.
26. Zhu Y, Wang Y, Wang DH: Diuresis and natriuresis caused by activation of VR1-positive sensory nerves in renal pelvis of rats. Hypertension (2005) 46(4):992-997.
27. Zhu Y, Xie C, Wang DH: TRPV1-mediated diuresis and natriuresis induced by hypertonic saline perfusion of the renal pelvis. Am J Nephrol (2007) 27(5):530-537. (Pubitemid 47482011)
28. Xie C, Sachs JR, Wang DH: Interdependent regulation of afferent renal nerve activity and renal function: Role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors. J Pharmacol Exp Ther (2008) 325(3):751-757. (Pubitemid 351724311)
29. Wang Y, Wang DH: A novel mechanism contributing to development of Dahl salt-sensitive hypertension: Role of the transient receptor potential vanilloid type 1. Hypertension (2006) 47(3):609-614. (Pubitemid 43843884)
30. Tobian L, Lange J, Iwai J, Hiller K, Johnson MA, Goossens P: Prevention with thiazide of NaCl-induced hypertension in Dahl 'S' rats. Evidence for a Na-retaining humoral agent in 'S' rats. Hypertension (1979) 1(3):316-323.
31. Rostand SG, Kirk KA, Rutsky EA, Pate BA: Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med (1982) 306(21):1276-1279.
32. Thurman JM: Triggers of inflammation after renal ischemia/ reperfusion. Clin Immunol (2007) 123(1):7-13.
33. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med (1989) 320(6):365-376.
34. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR: Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (1999) 277(3 Pt 2):R922-R929. (Pubitemid 29458168)
35. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest (1996) 97(4):1056-1063. (Pubitemid 26070586)
36. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med (1996) 334(22):1448-1460.
37. Edelstein CL, Ling H, Schrier RW: The nature of renal cell injury. Kidney Int (1997) 51(5):1341-1351.
38. Lieberthal W, Levine JS: Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol (1996) 271(3 Pt 2):F477-F488. (Pubitemid 26328278)
39. Wang L, Wang DH: TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation (2005) 112(23):3617-3623. (Pubitemid 43739540)
40. Zhong B, Wang DH: TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice. Am J Physiol Heart Circ Physiol (2007) 293(3):H1791-H1798. (Pubitemid 47367229)
41. Wei Z, Wang L, Han J, Song J, Yao L, Shao L, Sun Z, Zheng L: Decreased expression of transient receptor potential vanilloid 1 impairs the postischemic recovery of diabetic mouse hearts. Circulation (2009) 73(6):1127-1132.
42. Harada N, Okajima K, Yuksel M, Isobe H: Contribution of capsaicin sensitive sensory neurons to antithrombin-induced reduction of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost (2005) 93(1):48-56. • Antithrombin treatment reduced hepatic I/R-induced injury, via CGRP-mediated increases in PGI2 and endothelial NOS levels, as well as COX-1 activity. (Pubitemid 40124254)
43. Wang LH, Luo M, Wang Y, Galligan JJ, Wang DH: Impaired vasodilation in response to perivascular nerve stimulation in mesenteric arteries of TRPV1-null mutant mice. J Hypertens (2006) 24(12):2399-2408. (Pubitemid 44684688)
44. Okajima K, Isobe H, Uchiba M, Harada N: Role of sensory neuron in reduction of endotoxin-induced hypotension in rats. Crit Care Med (2005) 33(4):847-854. (Pubitemid 40504398)
45. Mizutani A, Okajima K, Uchiba M, Isobe H, Harada N, Mizutani S, Noguchi T: Antithrombin reduces ischemia/reperfusioninduced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood (2003) 101(8):3029-3036. (Pubitemid 36857991)
46. 2 production and decreasing neutrophil activation and the inflammatory response.
47. Ueda K, Tsuji F, Hirata T, Takaoka M, Matsumura Y: Preventive effect of TRPV1 agonists capsaicin and resiniferatoxin on ischemia/ reperfusion-induced renal injury in rats. J Cardiovasc Pharmacol (2008) 51(5):513-520. •• Pre-ischemic treatment with capsaicin and resiniferatoxin reduced renal I/R-induced injury by decreasing the inflammatory response, via an enhancement of IL-10 expression and an attenuation of TNFα production.
48. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T, Tanaka K: Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull (2005) 28(9): 1635-1638. (Pubitemid 41324123)
49. Qin SL, Liu SL, Wang RR: Protective effect of capsaicin against myocardial ischemia-reperfusion injury of rat in vivo. Sichuan Da Xue Xue Bao Yi Xue Ban (2009) 39(4):550-554. • Pretreatment with capsaicin attenuated myocardial I/R-induced injury by activating TRPV1 the SP receptor in vivo.
50. Murai M, Tsuji F, Nose M, Seki I, Oki K, Setoguchi C, Suhara H, Sasano M, Aono H: SA13353 (1-[2-(1-Adamantyl)ethyl]-1- pentyl-3-[3-(4-pyridyl)propyl] urea) inhibits TNF-α production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo. Eur J Pharmacol (2008) 588(2-3):309-315.
51. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, Star RA: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int (2001) 60(6):2118-2128. (Pubitemid 33070455)
52. Zhong B, Wang DH: N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1. Am J Physiol Heart Circ Physiol (2008) 295(2):H728-H735. • OLDA enhanced SP and CGRP release, and OLDA-meditated activation of TRPV1 reduced I/R-related injury in the heart.
53. Rang WQ, Du YH, Hu CP, Ye F, Xu KP, Peng J, Deng HW, Li YJ: Protective effects of evodiamine on myocardial ischemia-reperfusion injury in rats. Planta Med (2004) 70(12):1140-1143. • Pretreatment with evodiamine provided protection against myocardial I/R-induced injury through the activation of TRPV1 and the release of CGRP; this effect was blocked by a TRPV1 antagonist. (Pubitemid 40101093)
54. Sexton A, McDonald M, Cayla C, Thiemermann C, Ahluwalia A: 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1. FASEB J (2007) 21(11):2695-2703. • 12(S)-HpETE dose-dependently increased coronary vasodilatation in isolated rat hearts and significantly attenuated I/R-induced injury; this effect was blocked by the addition of capsazepine. (Pubitemid 47372737)
55. 2 metabolite.
56. Zager RA, Altschuld R: Body temperature: An important determinant of severity of ischemic renal injury. Am J Physiol (1986) 251(1 Pt 2):F87-F93.
57. Rawls SM, Ding Z, Cowan A: Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats. Pharmacol Biochem Behav (2006) 83(4):508-516. (Pubitemid 43817120)
58. Docherty RJ, Yeats JC, Piper AS: Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurons in culture. Br J Pharmacol (1997) 121(7):1461-1467. (Pubitemid 27317561)
59. Liu L, Simon SA: 59. Capsazepine, a vanilloid receptor antagonist, inhibits nicotic acetylcholine receptors in rat trigeminal ganglia. Neurosci Lett (1997) 228(1):29-32. (Pubitemid 27288529)
60. Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, Clark N, Boyce S, Kerby J, Ali Z, Chou M et al: Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3 methoxyphenylacetate ester) iode-resiniferatoxin. J Pharmacol Exp Ther (2002) 303(3): 1052-1060. (Pubitemid 35424389)
61. Saito A, Yamamoto M: Acute oral toxicity of capsaicin in mice and rats. J Toxicol Sci (1996) 21(3):195-200. (Pubitemid 26341645)
62. NeurogesX Inc: NeurogesX' Qutenza (NGX-4010) receives positive committee recommendation in European Union. Press Release (2009): March 19.
63. NeurogesX Inc: NeurogesX receives European commission approval for Qutenza. Press Release (2009): May 21.
64. NeurogesX Inc: NeurogesX intiates phase III postherpetic neuropathy study with NGX-4010. Press Release (2005): June 15.
65. Winston Pharmaceuticals Inc: Vernon Hills, IL, USA (2009). www.winstonlabs/productdevelpment/civamide.asp
66. Sanofi-aventis: Winston Laboratories Inc announces licensing agreement with sanofi-aventis Canada Inc in Canada. Press Release (2008): November 07.
67. Winston Laboratories Inc: Getting Ready Corporation and Winston Laboratories Inc announce completion of merger. Press Release (2008): September 26.